ILAE-Europe

News

Alan Richens 1938-2021
World News

In memoriam: Alan Richens

We are saddened to report the death of Alan Richens, recognized internationally for his research and a major driving force behind the impressive developments in the clinical pharmacology of epilepsy which took place in the 70s and the 80s.

7 June, 2021
ILAE
About ILAE

Final results for election of ILAE regional officers

The Elections Committee is pleased to announce that the ILAE regional elections have been completed. The elected officers of the six Regional Boards for the 2021-2025 term are as follows. The Elections Committee congratulates all the elected officers and wishes them a successful service for the next four years.

25 May, 2021
JAMA Neurology
Clinical Research

Safety of Early Discontinuation of Antiseizure Medication After Acute Symptomatic Neonatal Seizures

In this comparative effectiveness study, no difference was found in functional neurodevelopment or epilepsy at age 24 months among children whose ASM was discontinued vs maintained at hospital discharge after resolution of acute symptomatic neonatal seizures. These results support discontinuation of ASM prior to hospital discharge for most infants with acute symptomatic neonatal seizures.

24 May, 2021
Definition & Classification
About ILAE

Comments needed on proposed Classification and Definition of Epilepsy Syndromes

The ILAE seeks your comments on four papers prepared by the Task Force on Nosology and Definitions that provide the definitions for the many epilepsy syndromes at various ages. These definitions will become the League’s formal positions on these syndromes once edited and approved. Deadline is 15 July.

19 May, 2021